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Human hepatitis delta virus (HDV) is the smallest RNA virus in genome. HDV genome is divided into a viroid-like sequence and
a protein-coding sequence which could have originated from diﬀerent resources and the HDV genome was eventually constituted
through RNA recombination. The genome subsequently diversiﬁed through accumulation of mutations selected by interactions
betweenthemutatedRNAandproteinswithhostfactorstosuccessfullyformtheinfectiousvirions.Therefore,weproposethatthe
conservation of HDV nucleotide sequence is highly related with its functionality. Genome analysis of known HDV isolates shows
that the C-terminal coding sequences of large delta antigen (LDAg) are the highest diversity than other regions of protein-coding
sequences but they still retain biological functionality to interact with the heavy chain of clathrin can be selected and maintained.
Since viruses interact with many host factors, including escaping the host immune response, how to design a program to predict
RNA genome evolution is a great challenging work.
1.Introduction
V i r u s e sa r eah e t e r o g e n e o u sc l a s so fa g e n t st h a tp a r a s i t i z e
every form of life including not only animals and plants
but also bacteria, archaea, and fungi. Viruses vary greatly
in particle size and morphology and in genetic complexity
and host range. There are the DNA and the RNA viruses
deﬁned by the type of nucleic acid present in the mature
virion particles. The genome size of the virus, be it a DNA
or RNA virus, determines the number of proteins encoded
by the viral genome. The minimal set of viral proteins
includes capsid and envelope structural proteins required
for the assembly of the virion particles and DNA or RNA
polymerase for replication of the viral genome. A subclass
of viruses, containing only few members, has been called
satellite viruses since their genome can be encapsidated
by their own coat proteins but require helper viruses for
providing envelopes for assembling mature virions.
T h el e n g t ho ft h eg e n o m eo faD N Av i r u sv a r i e sf r o m
a few kilo-bases (kb) to several hundred kb. The smallest
known DNA virus is the human hepatitis B virus (HBV)
which is 3.2kb long and contains four open reading frames
(ORFs) that encode the surface antigens, the core proteins,
a polymerase, and an X protein [1, 2]. Together with the
duck HBV (DHBV), the woodchuck hepatitis virus (WHV),
and the ground squirrel hepatitis virus (GSHV), they form
a family of DNA viruses called the hepadnaviruses [3]. The
genome size of RNA viruses is generally shorter than that of
DNA viruses and ranges approximately from 2 to 31kb. The
smallest RNA virus identiﬁed to date is the human hepatitis
D virus (HDV) which is about 1.7kb in size and contains
onlyoneORF[4–7].HDVrequiresthecoexistenceofHBVto
supply envelope proteins for its assembly into mature virions
and is, hence, a defective virus, or it is called a satellite virus
of HBV [4, 6]. Although HBV and other hepadnaviruses are
found in a number of mammals, HDV has thus far been
f o u n di nh u m a n s[ 8]. There is another unique class of RNA-
containing infectious agents called the viroid. Viroid RNA
is a circular genome with a few hundred nucleotides long
and carries no discernible coding sequences. Unlike other
RNA viruses, viroids exist as a naked form of RNA without
a capsid or coat-protein armor. Viroids are known to infect
many species of plants and have not been found in any other
life forms besides plants [9].2 Advances in Bioinformatics
The origin of viruses remains elusive and debatable
because there are no fossils of viruses. Currently, there
are two popular hypotheses to explain possible origin of
viruses, viz the “regressive” or “degeneracy hypothesis” and
the “cellular origin” or “vagrancy hypothesis” [10, 11]. The
“regressive hypothesis” is similar to the “endosymbiosis
hypothesis” which explains the origin of mitochondria and
chloroplasts. Both hypotheses propose that the two indis-
pensable cellular organelles that harbor their own genetic
content originated from small prokaryotic cells that came to
reside within some ancestral eukaryotic cells and gradually
degenerated to become organelles of speciﬁc biological
functions. Therefore, vaccinia viruses, each of which harbors
aDNAgenomeofabout200kbinsize,mighthaveoriginated
from parasitized smaller cells through successive reduction
of the genome size within the host cells. The currently
existing fact that, cell within cell, such as rickettsia and
Chlamydia, can only replicate within the host cells supports
the “regressive hypothesis.”
The “cellular origin hypothesis” is based on the ﬁnding
of the presence of plasmids and various types of mobile
elements, such as transposons and retrotransposon, in
the current prokaryotes and eukaryotes. When present in
ancient cells, these elements could evolve to become viruses
when they had gained new properties through evolutionary
divergence to enable them to escape from the entrapping
host cells to gain entry to and propagate in new hosts.
Retroviruses and HBV, despite being diﬀerent in the RNA or
DNA content, respectively, might have originated from the
same family of ancestral retrotransposons since replication
of both viral genomes involves reverse transcription [12, 13].
Hence, the distinguishing feature between the “regressive”
and the “cellular origin” hypotheses lies in the “loss” or
“gain” of genetic materials, respectively. Nonetheless, the
hypotheses are similar in the same prerequisite that viruses
evolved subsequent to the emergence of self-sustaining
cells on Earth. A third hypothesis, called the “coevolution
hypothesis”, postulates that viruses had evolved from the
ancient soup of complex protein and nucleic acid molecules
independent of the self-sustaining host cells and concurrent
in time point with the appearance of the ﬁrst cells on Earth
[14].
However, no single hypothesis can satisfactorily explain
the origin all known viruses. In this paper, we use the
smallest human RNA virus, HDV, to illustrate how this virus
c o u l dh a v ee v o l v e da n dd i v e r g e d .T h ee v o l u t i o no fl a r g e r
genome size of RNA viruses, such as retroviruses, ﬂaviruses,
picornavirus, and corona viruses, is not a subject in this
review.
2. MolecularBiology of HDV
HDV was ﬁrst discovered in HBV-infected patients by an
Italian physician, Mario Rizzetto, in 1977. It was originally
thought to be a new nuclear antigen associated with HBV
[15]. It was later proved to be a new virus that requires the
surface antigens of HBV (HBsAgs) to support its life cycle
and infectivity as clearly demonstrated in the experimental
animals, chimpanzee, and woodchuck [8, 16, 17]. Co- or
superinfection by HDV in HBV patients is closely correlated
with the more severe symptoms of liver disease HBV
infection alone [18, 19]. Studies have established that the
HDV genome is a negative circular RNA about 1.7kb long.
Electron microscopic observation has further revealed that
the HDV genome appears as a rod-shape structure under
nondenaturing conditions but the genome presents itself in
a circular form under denaturing conditions [20]. Extensive
intramolecular base-pairing of the single-stranded RNA
molecule results in the formation of the double-stranded
rod-like structure [20].
Most RNA viruses encode their own replicases or RNA-
dependent RNA polymerases (RdRp) essential for viral
genome replication. However, the HDV genome does not
carry a replicase gene rendering HDV totally dependent on
thehostreplicationmachineryforitspropagation[21].Ithas
been demonstrated that HDV uses the host DNA-dependent
RNA polymerases (DdRp) to facilitate the replication of
its genome and antigenome [21] through a double-rolling
circle mechanism (Figure 1) as the majority of viroids
does [22]. Unlike viroid, however, HDV requires the HDV
genome-encoded small delta antigen, SDAg, for replication.
Furthermore, HDV is 4-5-fold larger in genome size than the
viroid. In addition to the coding sequence, the HDV genome
contains a viroid-like sequence in both the genome and
the antigenome [23–25]. A ribozyme, a self-cleaving RNA
sequence, resides in the viroid-like sequence of the HDV
genome that cleaves a linear form of multiple-copy length
of the viral genome or antigenome into monomeric units
that are then circularized to complete the replication cycle
(Figure 1).
The HDV genome has only one ORF to encode two
isoforms of hepatitis delta antigen (HDAg) during repli-
cation. The small hepatitis delta antigen, SDAg, is a 24-
kDa protein composed of 195 amino acid residues; the
large hepatitis delta antigen, LDAg, is 27kDa and consists
of 214 residues [26, 27]. The two antigens are identical
at the N-terminal 195 residues. The extra 19 residues (or
20 residues in those HDV isolates from South America)
present in the C-terminus of LDAg are derived from RNA
editing catalyzed by the host enzyme, adenosine deaminase
acting on the RNA (ADAR), and converting the stop
codon (UAG) of the SDAg ORF into a tryptophan codon
(UGG), thus extending the coding sequence to terminate
at a downstream termination codon [28–34]. In the life
cycle of HDV, SDAg supports viral genome replication
while LDAg inhibits replication and promotes interaction
of the HDV genome with HBsAgs for virion packaging
[35–37]. In spite of the sharing of the same sequence of
195 amino acid residues between SDAg and LDAg, the
additional peptide sequence of 19-20 residues of LDAg
has a distinct biological function. The peptide sequence
containsanuclearexportsignal(NES)thatfacilitatesnuclear
exportation of HDAg and an isoprenylation recognition
motif that interacts with HBsAgs to form the HDV virions
[37–41].Advances in Bioinformatics 3
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Figure 1: HDV genome and replication. (a) Structural features of the HDV genome. The viral genome is a single-stranded circular RNA
molecule composing of the viroid-like and the HDAg-coding domains. The ribozyme sequence (Rz) in the viroid-like domain is shown
as a blue box. “A/G” in the HDAg-coding sequence indicates the nucleotide edited by the host ADAR leading to the synthesis of LDAg.
The beginning and the end of the circular genome are labeled as 1/1683. (b) Replication of the HDV genome by the double rolling-circle
replication model. The genome and antigenome of HDV are represented by blue or red circles and labeled as “G” or “αG”, respectively.
The open blue or red lines represent the primary transcription products composed of multimeric units of the viral genome or antigenome,
respectively. The location of Rz is denoted by the green or blue boxes in the genome and antigenome, respectively. Arrowheads indicate the
self-cleavage site of the ribozyme.
3. Diversityof HDV GenomeSequences
Based on the percentage of nucleotide identity of the
genome, HDV was initially classiﬁed into three genotypes,
designated genotypes I-III [4]. The distribution of various
HDV genotypes is closely associated with geographic origins
and disease outcomes [18]. Genotype I HDV is distributed
worldwide and causes hepatitis with a wide range of clinical
severity.GenotypeIIHDVisfoundmainlyinEastandNorth
Asia including Taiwan, Japan, and Siberia and infection
usually leads to less severe clinical manifestations than
genotype I infection. On the other hand, genotype III is
reported to cause a severe form of fulminant hepatitis and
hasonlybeenisolatedinthenorthernareaofSouthAmerica.
In addition, the nucleotide sequence of genotype III is the
mostdivergentamongstalltheisolatedHDVsequences[42].
Recently, an increasing number of HDV isolates have
been identiﬁed and sequenced. The classiﬁcation of HDV
thus changes from the three genotypes into the eight clades,
HDV1 to HDV8 [42, 43] .I nt h en e ws c h e m eo fH D Vc l a s -
siﬁcation, HDV1-3 has replaced genotypes I-III, respectively.
HDV isolates that belong to genotype II subgroup b are now
regrouped into the HDV4 class. The most recently isolated
HDV sequences derived from African patients are grouped
into HDV5 through to HDV8 [42, 43]. HDV sequences
isolated from various geographic locations of Africa are
found to be more divergent sequences isolated from other
continents suggesting that the ﬁrst HDV might have arisen
from Africans. Two related questions are then raised: (1)
How did the ﬁrst HDV originate and how was it evolved?
(2) Is HDV diversity correlated with the established waves of
human migration across continents?
Analysis of the nucleotide sequences of 43 HDV isolates
mined from databases in the public domain has revealed
that the percentage nucleotide sequence identity of the
complete HDV genome ranges from 64.1% to 76.4% in
comparison of each out-group [42]. The percentage identify
is the lowest (64.1%) between HDV3 and HDV 5 and the
highest (76.4%). However, the percentage identity of the
SDAg coding sequence ranges from 72.4% to 83.6% in
comparisonofeachout-groupinwhichthelowest(72.4%)is
found between HDV3 and HDV7 and the highest (83.6%) is
betweenHDV2andHDV5[42].Ahigherpercentageidentity
of the SDAg coding sequence than that of the complete
viral genomic sequence indicates that nucleotide sequence
diversity is more restricted to the functional region than
in the noncoding region. Proﬁling of nucleotide identities
from the 43 HDV isolates shows that, when compared to
the HDAg coding sequence, the more conserved nucleotide
sequence is found in the viroid-like sequence that contains a
ribozyme sequence (Figure 2). The reason for lower diversity
in the viroid-like region than in the HDAg coding sequence4 Advances in Bioinformatics
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Figure 2: Proﬁling of nucleotide identities of 43 HDV isolates.
The vertical-axis represents percentage nucleotide identity and the
horizontal-axis displays the whole viral genome sequence as the
relative length of 1800 nucleotides due to the alignment. The
ribozyme (Rz) in the genome and antigenome is indicated by the
green or blue box, respectively. The relative genomic position of the
the HDAg-coding sequence is also shown (red arrow-bar).
could be because of the usage of wobble codons in HDAg
translation contributing to a higher degree of tolerance of
nucleotide substitutions without aﬀecting the amino acid
residue. On the other hand, the ribozyme in the viroid-like
regionexertsitsfunctiondirectlyintheRNAsequenceandis,
hence, less tolerant to nucleotide changes. This proposition
is supported by a base substitution study that revealed a 2.4-
fold higher C-to-U substitution in the HDV coding sequence
than in the full-length genome echoing frequent C-to-U
codon degeneracy in the third base of codons [42].
4. The Originof HDV
The current hypothesis of the origin of HDV favors the
“cellular origin” concept because numerous studies have
found similarities in structures and sequences between the
nucleotide and protein sequences of cellular genes and the
coding and viroid-like sequences of HDV.
In a genomewide search for ribozyme sequences, it has
been found that an HDV-like sequence in the human CPEB3
gene encodes the cytoplasmic polyadenylation element-
binding protein 3 [44]. CPEB3 is a member of a family
of proteins that regulate mRNA polyadenylation and are
highly conserved among mammals. The ribozyme resides
in the second intron of CPEB3 but is dissimilar in the
primary nucleotide sequence to that of the HDV ribozyme.
However, the secondary structure of the CPEB3 ribozyme is
similar to that of the HDV ribozyme both of which serve
the function of self-cleavage of the multimeric precursor.
These ﬁndings provide a clue that the viroid-like sequence of
HDV could have arisen from an ancestral CPEB3 ribozyme
in the mammal. Two other HDV viroid-like sequences
with sequence similarity to a cellular RNA come from the
ﬁndings that the HDV genomic sequence from nucleotide
(nt) 683–724 is complementary to nt 10–55 of the 7SL
RNA sequence and the antigneomic sequence from nt 858–
899 is complementary to nt 188–233 also of the 7SL RNA
[45, 46]. Both complementary regions of the HDV sequence
are located adjacent to the viroid-like region and have 73%
to 77% nucleotide identity to the 7SL RNA [45].
A cellular protein, termed delta interacting protein A
(DIPA), is reported to interact with HDAg aﬀecting HDV
replication [47]. Alignment of the protein sequences of DIPA
and HDAg has revealed a sequence identity of 24% and
sequence similarity of 56% [47]. Both DIPA and HDAg are
similar in size and both form oligomers through a coiled-
coil domain. These authors have further proposed that the
DIPA gene is a homolog of HDV and that the capture
of some DIPA transcripts by a viroid-like sequence could
have initiated the evolution of the very ﬁrst HDV. Findings
of RNA recombination between diﬀerent HDV genotypes
in patients or in cell cultures support the idea that DIPA
transcripts and viroid-like sequence could join together [41,
48, 49]. Two diﬀerent groups of researchers have further
demonstrated that RNA recombination is through a switch
in the transcription templates [50, 51].
This “cellular origin hypothesis” then raises the inter-
esting questions of when and in what animal host(s) such
RNA recombination ﬁrst occurred. Since HDV has to coexist
with HBV for propagation, a ﬁrst guess would be that HDV
should have evolved in animals that were susceptible to
infection by hepadnaviruses. The most primitive HBV is
thought to DHBV found in ducks, the viral genome of which
contains three ORFs but lacks the X-protein ORF that is
found in the human HBV [2, 52]. However, no naturally
occurring HDV has so far been found in ducks nor in two
other mammals, woodchucks, and ground squirrels, despite
the presence of the X-protein ORF in the corresponding
hepadnaviruses. Taken together, it is highly likely that the
ﬁrst HDV originated in ancestral humans. Thereafter, HDV
coevolved with HBV and selected human cellular factors to
generate sequence diversity along with the many waves of
human migration to diﬀerent geographic localities.
5. HDV Sequence Diversity through Mutations
Followedby HostFactors’Selection
Mutations frequently occur as a result of nucleotide mis-
matches during DNA or RNA replication. In general, the
mutation rate of RNA viruses is higher than that of DNA
viruses because the ﬁdelity of base-pairing is lower during
RNA replication than DNA replication. Diversity of the RNA
genomeofHDVshould,therefore,bederivedprimarilyfrom
accumulation of mutations. Mutations that had occurred
in essential sequences that could lead to impairment of
virion formation could have been eliminated during viral
replication. In contrast, mutations in nonessential sequences
could have been preserved.
In addition to the ribozyme sequence in the viroid-like
region and the HDAg coding sequence, there are several
cis-elements important for HDV replication. An essential
cis-element is the promoter sequence that is recognized
by cellular DdRps for transcription. Another important cis
sequence is recognized by ADARs for RNA editing to result
in LDAg production.
Among the essential sequences for HDV replication
and maturation, the sequence encoding the C-terminalAdvances in Bioinformatics 5
Table 1: Alignment of the nucleotide sequences that encode the carboxyl terminal 19-20 residues of LDAg. The sequences are displayed in
three diﬀerent groups (HDV1 as Group I, HDV2 and HDV4 to HDV8 as Group II, and HDV3 as Group III). The amino acid residues that
constitutetheclathrinbox-bindingdomainandtheisoprenylationsignalareindicatedabovethenucleotidesequenceinasingle-letteramino
acid abbreviation. The nucleotide substitution percentage is indicated at right, in which the total nucleotide variations within in-groups are
indicated as “All” in the ﬁrst column. The percentage of nucleotide variation corresponding to the clathrin-box binding domain and the
isoprenylation site is shown in the second and third columns, respectively. The accession number of each HDV isolate is indicated at bottom.
Group Isolates∗ Nucleotide substitution percentage (%)
All Clathrin
Box
Isoprenylation
motif
I 3.24 (24/741) 3.60
(7/195) 0.19 (4/156) LFPSD CRPQ
CTCTTCCCAGCCGAT TGTCGACCCCAG
Ethiopia TGGGATATA.........T.....CCTCCCTTTTCTCCCCAGAGT---.....T......
US-1 .......................C.......CC............---............
US-2 ................................C............---.....T......
Nagasaki-2 ..............T....T.........................---............
Taiwan ......T......................................---............
TW2667 .............................................---............
China .............................................---............
Italy ..........................G..................---............
Nauru ..................T.........................C---.....T......
Cagliari ......C.....................................C---............
HDV-Iran ..................T.......A.....C............---.....T......
Lebanon ..................T....C........C............---............
Somalia ..................T..........................---............
II
LPLLE CTPQ
Japan TGGGTAAGCCCATCTCCCCCCCAACAACGCCTTCCACTCCTCGAG---TGTACCCCCCAA
Taiwan-3 ......CA.....................................---........T...
Miyako-37 ......C......................................---.....T......
TW2476 ......C......................................---............
Yakut-26 .......AT..GGT.......GGG..G..................---............
Yakut-62 .....C.AT..GG........GGG..G..................---............
Miyako .....TGA...TGGG.G....TCT.CC..................---............
L215 .....TG....TGGGAG....TCT.CC...T..............---............
Miyako-36 .....T.A...TCAG.....T.CT.CC..............T...---............
Taiwan-Tw-2b .....T.....TCAG.....T.CT.CC..................---............
AF209859 .....T.....TCAG.....T.CT.CC..................---............
Tokyo .....T.A...TCAG.....T.CT.CC..................---............
dFr2600 .......A...GGGA....SS.CT.CC..................---.....T......
dFr2005 ...........GGGAT....GTCT.CC..................---.....T......
dFr47 ......RR...GGGA....GG.CT.CC..................---.....T.....G
dFr910 ......GA...GGGA....GG.CT.CC..................---.....T.....G
dFr73 ...........GGGAG....GTCT.CC..................---.....T......
dFr2703 ...........GGRM....SS.CT.CC..................---.....T......
dFr48 ....GT.A.A.TC......G..CT.CC..................---.....T......
dFr2139 ....GT.A.GGTC......G.TCT.CC..............A...---..C.........
dFr2627 ....GT.A.A.TC......G..CT.CC..................---.....T......
dFr45 ....G.CCTAGTC.GA......CT.CC..................---............
dFr2158 ....G.CCTAGTC.GA......CT.CC..................---............
dFr2072 ....G.CAGAGTC.G.......CT.CC..................---............
dFr644 ....G.CAAAG.C.G.......CT.CC..................---............
dFr2736 ....G.CAA.A.C.G.......CT.CC..................---............
7.31 (25/342)
0.77
(3/390) 4.5 (12/312)
5.26 (18/342)
3.80 (13/342)
3.51 (6/171)
0.00 (0/114)
2.34 (4/171)
III 0.42 (1/180) 0 0 YYWVP CTQQ
Peru-1 TGGTATGGGTTTACCCCGCCTCCCCCCGGGTATTACTGGGTCCCAGGGTGCACCCAACAA
VnzD8624 ...........C................................................
VnzD8375 ............................................................
VnzD8349 ............................................................
∗The accession numbers of the sequences used were AF209859, AF209859; Cagliari, X85253; China, X77627; dFr45, AX741144; dFr47, AX741149; dFr48,
AX741164; dFr73, AX741154; dFr644, AX741169; dFr910, AX741159; dFr2005, AM183331; dFr2072, AM183330; dFr2139, AM183332; dFr2158, AM183333;
dFr2600, AM183326; dFr2627, AM183329; dFr2703, AM183328; dFr2736, AM183327; Ethiopia, U81989; HDV-Iran, AY633627; Italy, X04451; Japan,
X60193; L215, AB088679; Lebanon, M84917; Miyako, AF309420; Miyako-36, AB118845; Miyako-37, AB118846; Nagasaki-2, AB118849; Nauru, M58629;
Peru-1, L22063; Somalia, U81988; Taiwan, M92448; Taiwan-3, U19598; Taiwan-Tw-2b, AF018077; Tokyo, AB118847; TW2476, AF104264; TW2667,
AF104263; US-1, D01075; US-2, L22066; Vnzd8349, AB037948; Vnzd8375, AB037947; Vnzd8624, AB037949; Yakut-26, AJ309879;a n dYakut-62, AJ309880.6 Advances in Bioinformatics
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peptide of LDAg is highly variable among the HDV1-
8; 198ILFPADPPFSPQSCCRPQ214 in HDV1 (as Group I),
198GPSPPQQRLPLLECTPQ214 in HDV2 and HDV4-8 (as
Group II), and 198FTPPPPGYYWVPGCTQQ214 in HDV3
(as group III) (Table 1). The identity of the amino acid
sequence of the in-groups is almost 100%; however, the
nucleotide substitution of in-groups ranges from 0.42% to
7.31% (Table 1). There are three functional domains in this
shortpeptideofLDAg.Theyarethenuclearexportingsignal,
the clathrin heavy chain (CHC) interacting domain, and
the isoprenylation signal [39, 53–55]. There is no nucleotide
substitution occurring in the clathrin box and isoprenylation
motif within Group III, while 3.60% and 0.19% within
Group I, and 0.77% and 4.5% within Group II (Table 1). The
lower identity among the various clades could be attributed
to the relaxation of the amino acid sequence participating
in interaction with its counterparts of cellular proteins and
the ﬂexibility of cellular location. For example, the last four
amino acids called the CaaX box (C: cysteine; a: aliphatic
aminoacids;X:anyaminoacidexceptleucineandphenylala-
nine)isanisoprenylationsignalrequiredforinteractionwith
HBsAgs for virion maturation. The isoprenylation signal of
HDV1 (Group I) is 211CRPQ214, HDV2 and HDV4 through
to HDV8 (Group II) is 211CTPQ214, and HDV3 (Group III)
is 211CTQQ214. The original sequence encoding the CaaX
box may yet be unknown but one could envisage that any
nucleotide variations leading to the coding of a varied CaaX
box would be maintained as has, indeed, been observed in
various HDV sequences.
Our previous ﬁndings have shown a greater extent of
diversity in the sequence encoding for the CHC-interacting
domain which could vary in sequences and locations [54].
The HDV1 (Group I) and HDV 2 and HDV4-8 (Group II)
have a clathrin box sequence 199LFPAD203 and 206LPLLE210,
respectively, while the HDV3 (Group III) does not have
such a sequence (Table 1). Instead, HDV3 could still form
a complex with CHC through the sequence 205YYWV208 or
206YWVP209 viathe association withaCHC-adaptor protein,
AP-2. Such binding ﬂexibility could have further provided
higher tolerance in nucleotide polymorphism in the HDV
sequences.
6. Conclusion andPerspective
Interestingly, increasing lines of evidence show that the
capsid protein or genome of many other RNA viruses binds
to the same cellular factors as HDV does. For example, a
pull-down assay of the capsid protein of mosquito- and
blood-borne West Nile virus (WNV) has shown that the
CHC is one of interacting proteins of the viral capsid
protein [56]. Although the authors did not demonstrate that
the interaction between the capsid protein of WNV and
CHC is important for virion packaging, we could identify a
consensus sequence of the clathrin box motif in the capsid
proteins of all WNV isolates but not in the capsid proteins
of Japanese encephalitis virus (JEV), a Flavivirus closely
related to WNV (Table 2). Another example is the case of
the HDV genome binding to glyceraldehydes 3-phosphate
dehydrogenase (GAPDH), a key enzyme in glycolysis [57,
58]. The genomes of JEV and the tomato bushy stunt virus,
a plant virus, are also found to bind to GAPDH [59, 60].
Whether the sequence of the HDV genome responsible
for interaction with GAPDH also contributes to sequence
diversity of the HDV genome awaits further investigation.
As compared with many other satellite viruses which
derived from a deletion of helper viruses, HDV lacks
any similarity of nucleotide sequences of helper virus, the
HBV, and evolved from two distinct nucleotide components
through a recombination. In addition to discussing the
possible origin of HDV, in this review, we proposed that
the HDV nucleotide diversity could be resulted from the
selection of interacting with host factors. By using the
programs of PIST and PLATO, Anisimova and Yang analyzed
all three codon positions of HDAg from 33 HDV isolates
and explained that the HDV sequence diversity could be
resulted from the positive selection force by escaping host
immune response [61]. Nevertheless, it is a great challenge
to bioinformatic scientists to formulate a set of general rules
for the interpretation of the genome diversity in other RNA
viruses.
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